Sasha's decades of research focused on many aspects of influenza, including the antigenic and molecular evolution of seasonal and pandemic influenza viruses, mechanisms of drug resistance, new antiviral drug discovery, and the development of new influenza vaccines. He was well recognized for his substantial contributions to the development of the Russian live attenuated influenza vaccine that now has become a WHO platform of choice for the transfer of influenza vaccine technology to developing countries. Many isirv members may best recognize Sasha's efforts in building global laboratory capacity for influenza surveillance. Under his leadership, his Branch conducted training in methods of diagnosis and characterization of seasonal and H5N1 influenza viruses for all 50 US State Public Health Laboratories and for hundreds of laboratorians in international ministries of health. His group produced influenza detection and characterization reagent kits for nearly 400 laboratories worldwide and provided around the clock diagnostic and surveillance support for influenza virus outbreak investigations. Sasha and his group provided laboratory support for over 25 outbreak investigations, from the first identification of H5N1 virus in humans in Hong Kong in 1997 to the emergence of H3N2v in the US in the summer and fall of 2012. In 2009, Sasha and his group were the first to identify and describe the molecular characteristics of the novel swineorigin pandemic H1N1 virus.
Over the years, Sasha served frequently as a temporary advisor to the World Health Organization, the US Food and Drug Administration (FDA), and the Association of Public Health Laboratories. He also was an active member of the Neuraminidase Inhibitor Susceptibility Network, now known as the ISIRV Antiviral Group. His scientific legacy is evident in the more than 220 peer-reviewed research publications, two US patents, and several key chapters on laboratory methods. Most notably, he contributed to articles that characterized the first H5N1 viruses infecting humans in Hong Kong in 1997, the 2009 pandemic virus, the novel influenza A (H3N2) v that infected over 300 people in 2012, as well as an article that identified a high level of antiviral resistance in influenza A (H3N2) Shepard Science Award, a prestigious and highest honor CDC award for scientific excellence, in addition to numerous FDA, CDC, and other federal agency awards recognizing his contributions to the detection of pandemic and emerging influenza A viruses with high public health consequence. He was also recognized by the Academy of Medical Sciences of the USSR for his study of live attenuated influenza vaccines.
Sasha was widely sought after as a CDC representative and speaker, particularly for his expertise on the influenza vaccine virus selection process, the development of improved molecular diagnostics for influenza, and the detection of antiviral drug resistance. He liked to use his artistic knowledge and skills in his presentations and often delighted his audiences with unique analogies and artwork that illustrated the challenges associated with the vaccine virus selection process. Over the years, Sasha served frequently as a temporary advisor to the World Health Organization, the Pan-American Health Organization, the US FDA, US Department of Agriculture, and National Institutes of Health. These appointments attest to the high regard in which he was held within the influenza research and public health community.
Sasha's scientific contributions to the field of influenza were truly outstanding, but he will be best remembered by many at CDC and around the world for his superb mentorship, his kind and extremely generous nature, and his wry sense of humor which endeared him to all who knew him well. In addition to his professional accomplishments, Sasha was an avid collector of beautiful seashells and was a gifted artist. His caricatures of his coworkers and international colleagues adorn the walls of many offices and homes around the world. Sasha's ability to capture the essence of those he knew in a few strokes of a brush or pen was extraordinary. He is survived by his wife Marina Khristova, son Peter and daughter Tatyana, and their families including five beautiful granddaughters. We have lost a remarkable leader and colleague in the world of influenza and above all, a gracious gentleman and friend. Sasha will be dearly missed by all who had the honor of knowing him. Jacqueline Katz, Julie Villanueva, Ann Moen, Nancy Cox Influenza Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. 
